PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.170
-0.130 (-10.00%)
At close: Nov 5, 2026, 4:00 PM EST
1.190
+0.020 (1.71%)
After-hours: Nov 5, 2026, 7:56 PM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $84.79 million as of November 5, 2026. It is the 26,021st most valuable company in the world and the 4,185th biggest in the United States. Its market cap has increased by 102.95% in one year.
Market Cap
84.79M
Enterprise Value
83.56M
1-Year Change
102.95%
Global Rank
Country Rank
#4,185 United States
Category
ChartMarket Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has increased from $45.51M to $84.79M, an increase of 86.31%. That is a compound annual growth rate of 8.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 84.79M | 101.30% |
| Dec 31, 2025 | 42.12M | -30.92% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 90.37M |
| Seer, Inc. | 90.26M |
| Retension Pharmaceuticals | 89.31M |
| Tevogen | 87.50M |
| Cibus | 87.13M |
| Polaryx Therapeutics | 86.73M |
| Rallybio | 84.47M |
| Genelux | 81.56M |